Clinical Trial Update: SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment

View source ↗

Summary

Clinical trial update for SL-START evaluating sublingual apomorphine titration schemes in real-world treatment for Parkinson disease; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Apomorphine (sublingual formulation) (apomorphine)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson Disease | Status: RECRUITING